VARIANT CJD (vCJD) or nvCJD

New Variant Creutzfeldt Jakob Disease nvCJD, was linked to young people and BSE in the U.K., aka mad cow disease...

About Me

My Photo
Name:
Location: BACLIFF, Texas, United States

My mother was murdered by what I call corporate and political homicide i.e. FOR PROFIT! she died from a rare phenotype of CJD i.e. the Heidenhain Variant of Creutzfeldt Jakob Disease i.e. sporadic, simply meaning from unknown route and source. I have simply been trying to validate her death DOD 12/14/97 with the truth. There is a route, and there is a source. There are many here in the USA. WE must make CJD and all human TSE, of all age groups 'reportable' Nationally and Internationally, with a written CJD questionnaire asking real questions pertaining to route and source of this agent. Friendly fire has the potential to play a huge role in the continued transmission of this agent via the medical, dental, and surgical arena. We must not flounder any longer. ...TSS

Thursday, February 06, 2014

Commons Science and Technology Committee announce new inquiry on blood, tissue and organ screening Parliament exposure vcjd and blood risk while still ignoring recent risks factors of sporadic CJD

Commons Science and Technology Committee announce new inquiry on blood, tissue and organ screening Parliament exposure vcjd and blood risk while still ignoring recent risks factors of sporadic CJD

 

Blood, tissue and organ screening

A parliamentary inquiry has been launched today into the safety of blood, tissue and organ screening following fears that vCJD – the human form of ‘mad cow’ disease – may be being spread by medical procedures.
http://www.parliament.uk/business/committees/committees-a-z/commons-select/science-and-technology-committee/inquiries/parliament-2010/blood-tissue-and-organ-screening/

 

Blood, tissue and organ screening


A parliamentary inquiry has been launched today into the safety of blood, tissue and organ screening following fears that vCJD – the human form of ‘mad cow’ disease – may be being spread by medical procedures.

Written submissions



At a hearing in Parliament last Wednesday, the Science and Technology Committee was told that vCJD continued to pose a “significant” risk to UK public health and that more than one in every 2000 people could be silent carriers of the disease. vCJD can have an incubation period of over 30 years.
Leading scientific experts told the Committee that the infectious agent responsible for vCJD—a type of abnormal protein called a prion—could be present in the UK blood supply and that blood and organ donation could therefore represent a major source of future vCJD infections.
Following this session, the Science and Technology Committee has agreed to hold an inquiry into blood, tissue and organ screening. Chair of the Committee Andrew Miller MP stated:
“Variant Creutzfeldt-Jakob Disease is a terrible condition and we were extremely concerned to hear evidence that this incurable disease still poses a significant risk to public health.
Although the risk of developing the disease as a result of eating contaminated beef was long ago eliminated, it is possible that the infection could still be unwittingly spread through medical procedures. We were told that this may happen through failure to properly clean medical instruments, or, even more worryingly, through widespread contamination of the blood and organ supply.
We want to explore whether the Government is taking this threat as seriously as it should be. Our new inquiry will investigate these issues in more detail and consider ways in which the UK can protect its vital supply of donated blood, tissues and organs.”The new inquiry follows on from a one-off evidence session that took place on Wednesday 27 November.



News


http://www.parliament.uk/business/committees/committees-a-z/commons-select/science-and-technology-committee/inquiries/parliament-2010/blood-tissue-and-organ-screening/

27 November 2013
The Science and Technology Committee has decided to hold an oral evidence session on variant Creutzfeldt-Jakob Disease (vCJD) and the ongoing risk it poses to the UK.

Witnesses

Wednesday 27 November 2013, Thatcher Room, Portcullis House
At 9.05 am
  • Dr Roland Salmon, Joint Chair, Advisory Committee on Dangerous Pathogens TSE Sub Group
  • Professor James Ironside, Professor of Clinical Neuropathology, National CJD Research and Surveillance Unit, University of Edinburgh
  • Professor John Collinge, Professor of Neurology at the UCL Institute of Neurology and Director of the MRC Prion Unit
The Committee will hear evidence from scientific experts on the potential prevalence of vCJD in the population, modes of ongoing transmission and current UK surveillance, control and prevention strategies.
Andrew Miller MP, Chair of the Science and Technology Committee, said:
“More than twenty years on from the BSE crisis, studies have suggested that thousands of people may still carry the infectious agent thought to cause variant Creutzfeldt-Jakob Disease—the human form of “mad cow disease”.
“Although these people may never go on to develop symptoms of vCJD, important questions remain to be asked about the potential risk posed by this terrible condition and what the Government should be doing to reduce the spread of infection.”

Further information

Image: Parliamentary copyright

Publications

  • Close

    Glossary

    • Reports and associated evidence – Reports of Committee inquires. This category may also include Special Reports where they are used by a Committee to bring matters relating to conduct of its business to the notice of the House.
    • Responses to Reports - Responses may be published as a Special Report, or as a Command Paper. They may also be appended to a Report should the Committee have substantial comments on the Response, in which case they can be found listed under Reports. 
    • Other oral and written evidence - Evidence taken by the Committee that has yet to or did not result in the publication of a Report. This includes transcripts of recent meetings.
    • Estimate Memoranda - An Estimate memorandum is an explanatory note that accompanies a government department’s estimate (a means by which a department seeks authority from Parliament for its spending plans).
    • Correspondence - Correspondence sent from or received by the Committee or its Chair.
  • 27 Nov 2013 - variant Creutzfeldt-Jakob Disease (vCJD) - oral evidence | PDF version (PDF313 KB) Opens in a new window Published 03 Dec 2013 Evidence given by Professor James Ironside, Professor of Clinical Neuropathology, National CJD Research and Surveillance Unit, University of Edinburgh, Dr Roland Salmon, Joint Chair, Advisory Committee on Dangerous Pathogens TSE Sub Group, and Professor John Collinge, Professor of Neurology, UCL Institute of Neurology and Director of the MRC Prion Unit.


http://www.parliament.uk/business/committees/committees-a-z/commons-select/science-and-technology-committee/inquiries/parliament-2010/vcjd/
 

Public Health (06-02-2014)

Patient Safety: New EU Rapid Alert platform for human Blood and Blood Components

A new platform launched by the European Commission will improve the safety of patients that undergo medical treatment involving blood and blood products.

From today, national health authorities can use the web-based Rapid Alert system for Blood and Blood Components (RAB) that allows them to exchange information so that cross-border incidents are prevented or contained and immediate measures can be taken to ensure the safety of patients. RAB will be used in parallel with existing national vigilance systems which collect and manage the alerts related to blood donated and used in the same Member State.

Due to the high volume of blood donated and transfused every year in the EU - more than 24 million units of blood and blood components were issued and over 2 million patients were transfused in 2011 alone - vigilance of all blood and its components transmitted across borders is of great importance. RAB supports this by allowing quick communication of the information needed for national authorities to take appropriate measures.

In addition to quality and safety defects of blood and blood components, the RAB can be used to raise the alarm on medical devices used for blood treatment and testing in this field, as well as on developing epidemiological situations (e.g. disease outbreaks) which may have cross-border implications on donation.

For more information on blood:


http://ec.europa.eu/health/blood_tissues_organs/blood/index_en.htm



http://ec.europa.eu/dgs/health_consumer/dyna/enews/enews.cfm?al_id=1451



Monday, February 03, 2014

 

CREUTZFELDT-JAKOB DISEASE T.S.E. PRION U.K. UPDATE As at 3rd February 2014

 

 I know the U.K. government, and the media, has squashed sporadic CJD, under a spontaneous myth, and the very real concerns there from, and the junk science that goes with it, all to protect the industry. but I thought you all might like to read the latest, what I call, the rest of the story, or nightmare. you all are missing the bigger picture, i.e. sporadic CJD and all the rest of the human and animal TSE prion disease, and the ramifications for friendly fire there from. I have supported the campaigning Mom, for her son Andrew, that died from nvCJD at a very young age, I have fully supported and helped her many times, and I _applaud_ them. but I am astounded of the silence, the medias silence, and every one else silence, on the many different strains and faces of sporadic CJD, and the other many different human TSE prion diseases that are mounting, that are linked to other animal TSE prion disease in some ways...the silence is deafening$ seems we have not learned our past mistakes. the final chapter of the mad cow saga is far from over, this book has not even been cracked open good yet. the silence is deafening. ...

 

kind regards, terry

 

see full text ;

 

 

Monday, February 03, 2014

 

CREUTZFELDT-JAKOB DISEASE T.S.E. PRION U.K. UPDATE As at 3rd February 2014

 


 

 

Saturday, February 01, 2014

 

vCJD With Extremely Low Lymphoreticular Deposition of Prion Protein MAY NOT HAVE BEEN DETECTABLE

 


 

 

Thursday, January 2, 2014

 

*** CWD TSE Prion in cervids to hTGmice, Heidenhain Variant Creutzfeldt-Jacob Disease MM1 genotype, and iatrogenic CJD ???

 


 

 

Friday, January 10, 2014

 

*** vpspr, sgss, sffi, TSE, an iatrogenic by-product of gss, ffi, familial type prion disease, what it ???

 


 

 

Monday, January 13, 2014

 

*** Prions in Variably Protease-Sensitive Prionopathy: An Update Pathogens 2013

 

Pathogens 2013, 2, 457-471; doi:10.3390/pathogens2030457

 


 

 

Wednesday, January 15, 2014

 

*** INFECTION PREVENTION AND CONTROL OF CJD, VCJD AND OTHER HUMAN PRION DISEASES IN HEALTHCARE AND COMMUNITY SETTINGS Variably Protease-Sensitive Prionopathy (VPSPr) January 15, 2014

 


 

 

Monday, December 02, 2013

 

*** A parliamentary inquiry has been launched today into the safety of blood, tissue and organ screening following fears that vCJD – the human form of ‘mad cow’ disease – may be being spread by medical procedures

 


 

Wednesday, December 11, 2013

 

*** Detection of Infectivity in Blood of Persons with Variant and Sporadic Creutzfeldt-Jakob Disease ***

 


 


 

 

Tuesday, October 29, 2013

 

*** VARIANT CJD PRESENTS DIFFERENTLY IN OLDER PATIENTS

 


 

 

 
Sent: Thursday, January 30, 2014 9:30 AM
Subject: Blood, tissue and organ screening SINGELTARY SUBMISSION
 

Blood, tissue and organ screening SINGELTARY SUBMISSION
 
 
I kindly wish to submit a late submission, do to the fact I don’t recall seeing this. please use the information as you wish.
 
Thank You,
 
Sincerely,
 
Terry S. Singeltary Sr.
 
 
Sent: Tuesday, December 10, 2013 6:18 PM
Subject: Re: A parliamentary inquiry has been launched today into the safety of blood, tissue and organ screening following fears that vCJD – the human form of ‘mad cow’ disease – may be being spread by medical procedures
 
Thank You Kindly !
 
 
kindest regards,
terry
 
 
 
 
Terry S. Singeltary Sr.
P.O. Box 42
Bacliff, Texas USA 77518
 
 
P.S. for your further information.....
 
 
 
Sent: Thursday, January 23, 2014 9:51 PM
Subject: Medical Devices Containing Materials Derived from Animal Sources (Except for In Vitro Diagnostic Devices) [Docket No. FDA–2013–D–1574]
 
Medical Devices Containing Materials Derived from Animal Sources (Except for In Vitro Diagnostic Devices) [Docket No. FDA–2013–D–1574] 
 
Terry S. Singeltary Sr. Submission [Docket No. FDA–2013–D–1574] 
 
 
Medical Devices Containing Materials Derived from Animal Sources (Except for In Vitro Diagnostic Devices)
 
 

Thursday, January 23, 2014

 

Medical Devices Containing Materials Derived from Animal Sources (Except for In Vitro Diagnostic Devices) [Docket No. FDA–2013–D–1574]

 


 

 

 

 
Sent: Tuesday, December 03, 2013 4:49 AM
Subject: Written submission to House of Commons Science and Technology Committee inquiry
 

Parliament UK
Thank you for your written submission to the House of Commons Science and Technology Committee inquiry on Blood, tissue and organ screening.
We will be in touch if we have any further questions.
 
 

 

WHAT about the sporadic CJD TSE proteins ?

 

WE now know that some cases of sporadic CJD are linked to atypical BSE and atypical Scrapie, so why are not MORE concerned about the sporadic CJD, and all it’s sub-types $$$

 

Creutzfeldt-Jakob Disease CJD cases rising North America updated report August 2013

 

*** Creutzfeldt-Jakob Disease CJD cases rising North America with Canada seeing an extreme increase of 48% between 2008 and 2010 ***

 


 

 

Sunday, October 13, 2013

 

*** CJD TSE Prion Disease Cases in Texas by Year, 2003-2012

 


 

 

Sunday, January 19, 2014

 

*** National Prion Disease Pathology Surveillance Center Cases Examined1 as of January 8, 2014 ***

 


 

 

TSEAC 2014 MEETING ???

 

I WAS TOLD LAST WEEK THERE ARE NO SCHEDULED TSEAC MEETING FOR 2014...TSS

 

 

Sent: Wednesday, February 05, 2014 9:29 AM
Subject: RE: 8720 FW: Blood, tissue and organ screening SINGELTARY SUBMISSION
 

Dear Mr. Singeltary:
 
Thank you for your recent inquiry to the Center for Biologics Evaluation and Research (CBER). CBER, one of seven centers within the Food and Drug Administration (FDA), is responsible for the regulation of many biologically-derived products, including blood intended for transfusion, blood components and derivatives, vaccines, allergenic extracts, and cell, tissue and gene therapy products. We hope the following information will be helpful.
 
Currently, there are no TSEAC meetings on the schedule for 2014, but that does not mean there aren’t going to be any meetings this year.  You can sign up for notifications of Advisory Committee meetings at the following website: http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm.  Alternatively, you can check the Advisory Committee Calendar posted on the same page. 
 
Additional information is also available through the OC-Advisory Committee Oversight and Management Staff.  For your convenience, I have copied their contact information below:
 
OC-Advisory Committee Oversight and Management Staff 
Food and Drug Administration
10903 New Hampshire Avenue
WO32 - 5129
Silver Spring, MD 20993-0002
Phone:     301-443-0572
Phone:     1-800-741-8138
 
We hope this information has been helpful. 
 
 
Sincerely,
 
Hope Anderson Consumer Safety Officer Consumer Affairs Branch
Division of Communication and Consumer Affairs
Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Follow us on Twitter: http://www.twitter.com/fdacber
 This informal communication represents my best judgment at this time. It does not constitute an advisory opinion in accordance with 21 CFR 10.85, and does not necessarily represent the formal position of FDA or otherwise obligate the agency to the views expressed.
 
 
From: Terry S. Singeltary Sr. [mailto:flounder9@verizon.net]
Sent: Thursday, January 30, 2014 11:05 AM
To: CBER OCOD Consumer Account
Cc: Emery, Bryan (CBER); Monser, Martha; mmturner@gwu.edu; pschwartz@choc.org; parisi.joseph@mayo.edu; bcaughey@nih.gov; patrick.bosque@dhha.org; APPLEBB@ccf.org
Subject: Fw: Blood, tissue and organ screening SINGELTARY SUBMISSION
 
Greetings FDA TSEAC et al,
 
I am concerned about recent revelations with TSE prion science, disturbing new risk factors, and the fact I see no upcoming TSEAC meetings about these risk factors.
 
could you please tell me when the next TSEAC meeting will be, and if there will be any in 2014, and if you will addressing any of these new risk factors ???
 
Thank You,
 
kind regards,
terry
 
 
 
Sent: Thursday, January 30, 2014 9:30 AM
Subject: Blood, tissue and organ screening SINGELTARY SUBMISSION
 
Blood, tissue and organ screening SINGELTARY SUBMISSION
 
 
03 December 2013
A parliamentary inquiry has been launched today into the safety of blood, tissue and organ screening following fears that vCJD – the human form of ‘mad cow’ disease – may be being spread by medical procedures.
  • Inquiry: Blood, tissue and organ screening
  • Inquiry: variant Creutzfeldt-Jakob Disease (vCJD)
  • Science and Technology Committee
 
 
SNIP...END...TSS
 
 
 
 Monday, December 02, 2013
 
*** A parliamentary inquiry has been launched today into the safety of blood, tissue and organ screening following fears that vCJD – the human form of ‘mad cow’ disease – may be being spread by medical procedures
 
 
 

 

 

Sunday, June 9, 2013

 

TSEAC March 14, 2013: Transmissible Spongiform Encephalopathies Advisory Committee Meeting Webcast

 


 

 

 

Sunday, February 2, 2014

 

The Presence of Disease-Associated Prion Protein in Skeletal Muscle of Cattle Infected with Classical Bovine Spongiform Encephalopathy

 

NOTE Pathology

 


 

 

 

 

 

TSS

 




 

posted by Terry S. Singeltary Sr. | 12:24 PM

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home